Skip to content

A Randomized, Controlled, Parallel-Group, Investigator-Initiated Trial to Evaluate the Efficacy, and Safety of the Use of Laryngeal Mask Compared to Endotracheal Intubation During Anesthesia in Pediatric Strabismus Surgery to Prevent Clinically Relevant Postoperative Nausea and Vomiting and Emergence Delirium Using Risk-Adapted Postoperative Nausea and Vomiting Prophylaxis

A Randomized, Controlled, Parallel-Group, Investigator-Initiated Trial to Evaluate the Efficacy, and Safety of the Use of Laryngeal Mask Compared to Endotracheal Intubation During Anesthesia in Pediatric Strabismus Surgery to Prevent Clinically Relevant Postoperative Nausea and Vomiting and Emergence Delirium Using Risk-Adapted Postoperative Nausea and Vomiting Prophylaxis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029612
Enrollment
162
Registered
2022-11-22
Start date
2022-07-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R11 T88.5 F05.8

Interventions

Group 1: The patient undergo strabism surgery under general anaesthesia. In order to secure the airway patients are intubated endotracheally for the duration of the anaesthesia. The surgery/anaesthesi

Sponsors

Universitätsklinikum des Saarlandes, Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: Subjects undergoing elective strabismus surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Subjects with American Society of Anesthesiologists Physical Status Classification III or higher, Subjects participating in another clinical trial

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting 6 hours postoperative

Secondary

MeasureTime frame
Incidence of nausea and vomiting 2 and 24 hours postoperative, Incidence of emergence delir, other adverse events until discharge

Countries

Germany

Contacts

Public ContactEmanuela Morinello

Universitätsklinikum des Saarlandes, Klinik für Anästhesiologie

emanuela.morinello@uks.eu06841-16-22485

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026